Literature DB >> 4070952

Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man.

J Bülow, L Friberg, O Gaardsting, M Hansen.   

Abstract

Cooling of the scalp has been found to prevent hair loss following cytostatic treatment, but in order to obtain the hair preserving effect the subcutaneous temperature has to be reduced below 22 degrees C. In order to establish the relationship between epicutaneous and subcutaneous temperatures during cooling and rewarming and to measure the effect of scalp cooling on subcutaneous scalp blood flow, subcutaneous blood flow and epi- and subcutaneous temperatures were measured in the frontal region at the hairline border before and during cooling with a cooling helmet, during spontaneous rewarming of the cooling helmet and after removal of the rewarmed helmet in 10 normal subjects. Subcutaneous blood flow was reduced to about 25% of the postcooling control level during cooling. The flow was constantly reduced until the subcutaneous temperature exceeded 30-32 degrees C. A linear relationship between epicutaneous and subcutaneous temperatures could be demonstrated with the regression equation: s = 0.9 c + 4.9 (r = 0.99). In eight of the 10 subjects the subcutaneous temperature could be reduced below 22 degrees C with the applied technique. It is concluded that the hair preserving effect of scalp cooling during cytostatic treatment is mainly due to the metabolic effect of cooling, and only to a minor extent due to the flow reducing effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4070952     DOI: 10.3109/00365518509155250

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  19 in total

1.  Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.

Authors:  Hope S Rugo; Paula Klein; Susan Anitra Melin; Sara A Hurvitz; Michelle E Melisko; Anne Moore; Glen Park; Jules Mitchel; Erika Bågeman; Ralph B D'Agostino; Elizabeth S Ver Hoeve; Laura Esserman; Tessa Cigler
Journal:  JAMA       Date:  2017-02-14       Impact factor: 56.272

Review 2.  A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.

Authors:  Christopher John Dunnill; Wafaa Al-Tameemi; Andrew Collett; Iain Stuart Haslam; Nikolaos Theodoros Georgopoulos
Journal:  Oncologist       Date:  2017-09-26

3.  Chemotherapy drug concentrations in hair follicles: a potential biomarker to monitor the effectiveness of scalp cooling for chemotherapy-induced alopecia.

Authors:  Jung-Woo Chae; Raymond Ng; Alexandre Chan
Journal:  Support Care Cancer       Date:  2018-06-26       Impact factor: 3.603

4.  Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.

Authors:  Manon M C Komen; Corina J G van den Hurk; Johan W R Nortier; Tjeerd van der Ploeg; P Nieboer; Jacobus J M van der Hoeven; Carolien H Smorenburg
Journal:  Support Care Cancer       Date:  2018-09-11       Impact factor: 3.603

5.  Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia.

Authors:  Manon M C Komen; Carolien H Smorenburg; Corina J G van den Hurk; Johan W R Nortier
Journal:  Oncologist       Date:  2013-05-06

6.  Natural cooling of the brain during outdoor bicycling?

Authors:  B Nielsen
Journal:  Pflugers Arch       Date:  1988-04       Impact factor: 3.657

7.  Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy.

Authors:  I G Ron; Y Kalmus; Z Kalmus; M Inbar; S Chaitchik
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

Review 8.  Hair disorders in patients with cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

9.  Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.

Authors:  Mona Ridderheim; Maria Bjurberg; Anita Gustavsson
Journal:  Support Care Cancer       Date:  2003-03-21       Impact factor: 3.603

10.  Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia.

Authors:  Viswanath Reddy Belum; Giselle de Barros Silva; Mariana Tosello Laloni; Kathryn Ciccolini; Shari B Goldfarb; Larry Norton; Nancy T Sklarin; Mario E Lacouture
Journal:  Breast Cancer Res Treat       Date:  2016-05-05       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.